Showing results (261-270 of 434) with videos related to
Sort By:
Pageof 44
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
A trial of integrated buprenorphine/naloxone and HIV clinical careLynn E Sullivan, Declan Barry, Brent A Moore, et al.The American Journal on Addictions|February 10, 2015
Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherenceEmily A Wang, Kathleen A McGinnis, Jessica B Long, et al.Journal of Studies on Alcohol and Drugs|May 22, 2024
Prescription Opioid Dose Change Before Fatal Opioid-Detected OverdoseMaryam Kazemitabar, Benjamin A Howell, William C Becker, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 1, 2022
How relevant are cerebral white matter lesions in the D313Y variant of the α-galactosidase A gene? Neurological, cardiological, laboratory, and MRI data of 21 patients within a follow-up of 3 yearsDaniel Strunk, Jana Becker, Roland Veltkamp, et al.Frontiers in Epidemiology|November 29, 2024
Using a computational cognitive model to simulate the effects of personal and social network experiences on seasonal influenza vaccination decisionsMatthew M Walsh, Andrew M Parker, Raffaele Vardavas, et al.Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 3, 2020
The Stability of Influenza Vaccination Behavior Over Time: A Longitudinal Analysis of Individuals Across 8 YearsMatthew M Walsh, Andrew M Parker, Raffaele Vardavas, et al.Frontiers in Epidemiology|June 29, 2026
Modeling the disruptive impact of the COVID-19 pandemic on nurses' supply and wagesRaffaele Vardavas, Pedro Nascimento De Lima, Lawrence Baker, et al.AIDS and Behavior|November 30, 2016
Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject DrugsE Jennifer Edelman, Brent A Moore, Sarah K Calabrese, et al.The American Journal on Addictions|April 9, 2008
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 yearsDavid A Fiellin, Brent A Moore, Lynn E Sullivan, et al.JAMA Network Open|July 14, 2025
Racial and Ethnic Factors and Opioid Use Disorder Treatment After an Emergency Department VisitEdouard Coupet, Marek C Chawarski, Kavari Hercules, et al.Pageof 44